Keyphrases
High Risk
100%
Penetrating Keratoplasty
100%
FK506
100%
Topical Tacrolimus
100%
Tacrolimus
50%
Ointment
50%
Tacrolimus 0.03%
50%
Once-daily Dosing
25%
Transplant Patients
25%
Long-term Efficacy
25%
Twice Daily
25%
Acute Rejection
25%
Therapeutic Agents
25%
Treatment Duration
25%
Tacrolimus Ointment
25%
Long Follow-up
25%
Fuchs Endothelial Corneal Dystrophy
25%
Corneal Transplantation
25%
Immunosuppressive Therapy
25%
Consecutive Patients
25%
No Adverse Effect
25%
Graft Rejection
25%
Herpes Simplex Virus Infection
25%
Immunosuppressive Agents
25%
Corneal Scar
25%
Acanthamoeba Keratitis
25%
Herpes Simplex Virus Reactivation
25%
Herpetic Keratitis
25%
Corneal Graft
25%
High-risk Grafts
25%
Protopic
25%
Keratoconus
25%
Steroid-induced Glaucoma
25%
Adverse Treatment Effects
25%
Pharmacology, Toxicology and Pharmaceutical Science
Tacrolimus
100%
Immunosuppressive Agent
33%
Virus Infection
11%
Acute Graft Rejection
11%
Herpes Simplex Virus
11%
Graft Rejection
11%
Herpes Simplex Keratitis
11%
Acanthamoeba Keratitis
11%
Congenital Cornea Dystrophy
11%
Glaucoma
11%
Keratoconus
11%
Side Effect
11%